SanjayGoelMD, MS

PubMed

• Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation status.
  Aaron Shaykevich, Danbee Chae, Isaac Silverman, Jeremy Bassali, Netanel Louloueian, Alexander Siegman, Gargi Bandyopadhyaya, Sanjay Goel, Radhashree Maitra> ;Investigational New Drugs. 2024 Apr 1
• Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
  Hiroyuki Arai, Yan Yang, Yasmine Baca, Joshua Millstein, Tadamichi Denda, Fang-Shu Ou, Federico Innocenti, Hiroyuki Takeda, Yohei Kubota, Ayako Doi, Yoshiki Horie, Kum...> ;European Journal of Cancer. 2024 Apr 1
• The Impact of Medicaid Expansion Under the Affordable Care Act on the Gap Between American Indians and Whites in Breast Cancer Management and Prognosis.
  Anu G Gaba, Li Cao, Rebecca J Renfrew, Deann Witte, Janet M Wernisch, Abe E Sahmoun, Sanjay Goel, Kristi A Egland, Ross D Crosby> ;Clinical Breast Cancer. 2024 Feb 1
• Noncoding RNA Profile in Reovirus Treated-Mutated Colorectal Cancer Patients.
  Rafael Saperstein, Sanjay Goel, Radhashree Maitra> ;Diseases. 2023 Oct 16
• Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer.
  Riya Patel, Abdissa Negassa, Seda S Tolu, Ana Acuna-Villaorduna, Sanjay Goel> ;Clinical Colorectal Cancer. 2024 Mar 1
• 1 citations
  Effect of Medicaid Expansion in Reducing Racial Disparities in Early Onset Colorectal Cancer.
  Shafia Rahman, Riya Patel, Jianyou Liu, Anu Gaba, Radhashree Maitra, Ana Acuna-Villaorduna, Mimi Kim, Sanjay Goel> ;Journal of Racial and Ethnic Health Disparities. 2023 Sep 14
• 1 citations
  Differences in Breast Cancers Among American Indian/Alaska Native and non-Hispanic Whites in the USA.
  Anu G Gaba, Li Cao, Rebecca J Renfrew, DeAnn Witte, Janet M Wernisch, Abe E Sahmoun, Sanjay Goel, Kristi A Egland, Ross D Crosby> ;Journal of Racial and Ethnic Health Disparities. 2023 Jul 11
• 2 citations
  Direct oral anticoagulant (DOACs) prescribing practices of members of the Society of Gynecologic Oncology and American Society of Clinical Oncology.
  Lauren R Scanlon, Bijan Khaksari, Sanjay Goel, Nicole S Nevadunsky, Jason D Wright, Gregory M Gressel> ;Gynecologic Oncology. 2023 Jun 1
• 1 citations
  Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors.
  Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, Sanjay Goel, Solmaz Sahebjam, James Strauss, Sant Chawla, Ding Wang, Diane R Mould, Vivek Samnotra, Douglas V Faller,...> ;Clinical Pharmacology in Drug Development. 2023 Mar 1
• 1 citations
  Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient Population.
  Matthew Lee, Emily Miao, Bruce Rapkin, Balazs Halmos, Viswanathan Shankar, Sanjay Goel> ;Vaccines. 2022 Oct 14
• 1 citations
  Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma.
  Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota, Amanda Jirgal, Rafi Kabarriti, Sarah Bellemare, Inessa Goldman, Andreas Kaubisch, Santiago Aparo, Sanjay Go...> ;Cancer Control. 2022 Oct 12
• 16 citations
  First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
  Todd Bauer, Byong Chul Cho, Rebecca Heist, Lyudmila Bazhenova, Theresa Werner, Sanjay Goel, Dong-Wan Kim, Douglas Adkins, Richard D Carvajal, Ajjai Alva, Keith Eaton, ...> ;Investigational New Drugs. 2022 Oct 1
• 13 citations
  Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open...
  Neeraj Agarwal, Bradley McGregor, Benjamin L Maughan, Tanya B Dorff, William Kelly, Bruno Fang, Rana R McKay, Parminder Singh, Lance Pagliaro, Robert Dreicer, Sandy Sr...> ;The Lancet. Oncology. 2022 Jul 1
• 1 citations
  Long-term avelumab in advanced non-small-cell lung cancer: summaries andanalyses from JAVELIN Solid Tumor.
  Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, David Spigel, Howard Safran, Matthew H Taylor, Jaafar Bennouna, Deborah J Wong, Karen Kelly, Claire Verschraegen, Mar...> ;Future Oncology. 2022 Apr 1
• 2 citations
  In silico comparative analysis of KRAS mutations at codons 12 and 13: Structural modifications of P-Loop, switch I&II regions preventing GTP hydrolysis.
  Michael Gerber, Sanjay Goel, Radhashree Maitra> ;Computers in Biology and Medicine. 2022 Feb 1
• 2 citations
  Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer.
  Titto Augustine, Peter John, Tyler Friedman, Jeeshan Jiffry, Hillary Guzik, Rifat Mannan, Riya Gupta, Catherine Delano, John M Mariadason, Xingxing Zang, Radhashree Ma...> ;Frontiers in Oncology. 2022 Jan 1
• 5 citations
  Therapeutic Targets of KRAS in Colorectal Cancer.
  Shafia Rahman, Shimon Garrel, Michael Gerber, Radhashree Maitra, Sanjay Goel> ;Cancers. 2021 Dec 11
• 4 citations
  Comparative Effectiveness of Biologic Agents Among Black and White Medicare Patients in the US With Metastatic Colorectal Cancer.
  Sanjay Goel, Abdissa Negassa, Ana Acuna-Villaorduna> ;JAMA Network Open. 2021 Dec 1
• 1 citations
  Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-19.
  Phaedon D. Zavras, Vikas Mehta, Sanjay Goel, Kith Pradhan, Henny H. Billett> ;Acta Haematologica. 2021 Oct 19
• 14 citations
  Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial.
  Joël Guigay, Keun Wook Lee, Manish R. Patel, Amaury Daste, Deborah J. Wong, Sanjay Goel, Michael S. Gordon, Martin Gutierrez, Ani Sarkis Balmanoukian, Christophe Le To...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
• 3 citations
  Transcriptome signature of immune cells post reovirus treatment in kras mutated colorectal cancer
  Elisha Fogel, Avishai Samouha, Sanjay Goel, Radhashree Maitra> ;Cancer Management and Research. 2021 Aug 27
• 250 citations
  Seroconversion rates following COVID-19 vaccination among patients with cancer.
  , , , , , , , , , , , , , , , , , , , , , > ;Cancer Cell. 2021 Aug 9
• 9 citations
  Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry
  Ajit Kumar, Preeti Kaushik, Sandra Incerpi, Jens Z. Pedersen, Sanjay Goel, Ashok K. Prasad, Vishwajeet Rohil, Virinder S. Parmar, Luciano Saso, Christophe Len> ;Molecules. 2021 Aug 8
• 45 citations
  Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-Type TP53.
  Mansoor N. Saleh, Manish R. Patel, Todd M. Bauer, Sanjay Goel, Gerald Steven Falchook, Geoffrey I. Shapiro, Ki Y. Chung, Jeffrey R. Infante, Robert M. Conry, Guilherme...> ;Clinical Cancer Research. 2021 Oct 1
• 75 citations
  Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy
  Astha Thakkar, Kith Pradhan, Shawn Jindal, Zhu Cui, Bradley Rockwell, Akash Pradip Shah, Stuart H. Packer, R. Alejandro Sica, Joseph A. Sparano, D. Yitzhak Goldstein, ...> ;Nature Cancer. 2021 Mar 22
• Join now to see all

Journal Articles

• Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case For Prophylaxis.  
  Swami U, Goel S, Mani S, Curr Drug Targets, 4/15/2013
• Evolvement of the treatment paradigm for metastatic colon cancer. From chemotherapy to targeted therapy.  
  Aparo S, Goel S, Crit Rev Oncol Hematol, 7/1/2012
• Eribulin-A review of preclinical and clinical studies.  
  Swami U, Chaudhary I, Ghalib MH, Goel S, Crit Rev Oncol Hematol, 2/1/2012
• Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors. Accepted. Cancer Chemotherapy and Pharmacology.  
  Lam ET, Goel S, Schaaf LJ, Cropp G, Hannah AL, Zhou Y, McCracken B, Haley BI, Johnson RG, Mani S, Villalona-Calero MA, Cancer Chemother Pharmacol, 1/1/2012
• Multicenter Phase II Study of Trabectedin in Patients with Metastatic Castration Resistant Prostate Cancer.  
  Michaelson MD, Bellmunt J, Hudes GR, Goel S, Lee RJ, Kantoff PW, Stein CA, Lardelli P, Pardos I, Kahatt C, Nieto A, Cullell-Young M, Lewis NL, Smith MR, Ann Oncol, 1/1/2012
• PTEN Gene Expression and Mutations in The PIK3CA Gene as Predictors of Clinical Benefit to Anti Epidermal Growth Factor Receptor Antibody Therapy In Patients With KRAS...  
  Sood A, McClain D, Maitra R, Basu-Mallick A, Seetharam R, Kaubisch A, Rajdev L, Mariadason JM, Tanaka K, Goel S, Clin Colorectal Cancer, 1/1/2012
• Safety, Pharmacokinetics and activity of EZN-2208, a Novel Conjugate of Polyethylene Glycol and SN38, in patients with advanced malignancies.  
  Kurzrock R, Goel S, Wheler J, Hong D, Fu S, Rezai K, Morgan-Linnell SK, Urien S, Mani S, Chaudhary I, Ghalib MH, Buchbinder A, Lokiec F, Mulcahy M, Cancer, 1/1/2012
• Novel Drugs Targeting the Epidermal Growth Factor Receptor and Its Downstream Pathways in the Treatment of Colorectal Cancer: A Systematic Review.  
  Merla A, Goel S, Chemotherapy Research and Practice, 1/1/2012
• Reovirus: A Targeted Therapeutic – Progress and Potential.  
  Maitra R, Ghalib MH, Goel S, Mol Cancer Res, 1/1/2012
• Metastatic Colorectal Cancer: A Paradigm for Personalized Medicine  
  Goel S, 2/1/2011
• Intestinal epithelial-specific PTEN inactivation results in tumor formation.  
  Byun DS, Ahmed N, Nasser S, Shin J, Al-Obaidi S, Goel S, Corner GA, Wilson AJ, Flanagan DJ, Williams DS, Augenlicht LH, Vincan E, Mariadason JM, Am J Physiol Gastrointest Liver Physiol, 1/1/2011
• Revised TNM staging for colorectal cancer: Did we miss the golden opportunity to do right by the staging?  
  Nayak J, Goel S, Clin Colorectal Cancer, 1/1/2011
• Therapeutic Oligonucleotides--The Road Not Taken.  
  Stein CA, Goel S, Clin Colorectal Cancer, 1/1/2011
• Phase II Study of Paclitaxel plus the Protein Kinase C Inhibitor Bryostatin-1 in Advanced Pancreatic Carcinoma.  
  Lam A, Sparano JA, Vinciguerra V, Ocean A, Christos P, Hochster H, Camacho F, Goel S, Mani S, Kaubisch A, Am J Clin Oncol, 1/1/2010
• Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gen...  
  Cancer Res, 1/1/2010
• Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-acetic acid) to Docetaxel in Castration-Refractory Metastatic Prostate Cancer.  
  Pili R, Rosenthal MA, Mainwaring PN, Van Hazel G, Srinivas S, Dreicer R, Goel S, Leach J, Wong S, Clingan P, Clin Cancer Res, 1/1/2010
• Oxaliplatin Resistance Induced by ERCC1 Upregulation is Abrogated by siRNA Mediated Gene Silencing in Human Colorectal Cancer Cells.  
  Seetharam RN, Sood A, Basu-Mallick A, Augenlicht LH, Mariadason JM, Goel S, Anticancer Research, 1/1/2010
• Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors.  
  Gollamudi R, Ghalib MH, Desai K, Chaudhary I, Wong B, Einstein M. Coffey M, Gill GM, Mettinger K, Mariadason JM, Mani S, Goel S, Invest New Drugs, 1/1/2010
• Bioequivalence of a new oral topotecan formulation relative to the current topotecan formulation in patients with advanced solid tumors.  
  Oostendorp RL, Loftiss J, Goel S, Smith DA, Dar MM, Witteveen PO, Cohen RB, Lewis LD, Kurian S, Patnaik A, Rosing H, Beijnen JH, Voesta EE, Burris H, Schellens HMS, Int J Clin Pharmacol Ther, 1/1/2009
• A Phase I Study Of Eribulin Mesylate (E7389), A Novel Inhibitor Of Microtubule Dynamics, In Patients With Advanced Solid Tumors.  
  Goel S, Mita A, Wong N, Rowinsky EK, Chu QS, Wong N, Desjardins C, Fang F, Jansen M, Shuster DE, Mani S, Takimoto CH, Clin Cancer Res, 1/1/2009
• An A13 Repeat within the 3’-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) is frequently mutated in Microsatellite Instability Colon Cancers and is Ass...  
  Yuan Z, Shin J, Wilson A, Goel S, Ling Y-H, Ahmed N, Dopeso H, Jhawer M, Nasser S, Montagna C. Fordyce K, Augenlicht LH, Aaltonen LA, Arango D, Weber TK, Mariadason JM, Cancer Res, 1/1/2009
• Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions.  
  Mani S, Ghalib M, Chaudhary I, Goel S, Expert Opin Drug Metab Toxicol, 1/1/2009
• Oxaliplatin: Preclinical perspectives on the mechanisms of action, response and resistance.  
  Seetharam RN, Sood A, Goel S., Ecancer Medical Science, 1/1/2009
• Novel Neurosensory Testing In Cancer Patients Treated With The Epothilone B Analog, Ixabepilone.  
  Goel S, Goldberg G, Kuo D Y-S, Muggia F, Arezzo J, Mani S, Ann Oncol, 1/1/2008
• A Phase 1 Open-Label, Accelerated Dose-Escalation Study of the Hypoxia-Activated Prodrug AQ4N in Patients with Advanced Malignancies.  
  Papadopoulos KP, Goel S, Beeram M, Beeram M, Wong A, Desai K, Haigentz M, Milian ML, Mani S, Tolcher A, Lalani AS, Sarantopoulos J, Clin Cancer Res, 1/1/2008
• Join now to see all

Abstracts/Posters

• Tumor Biology
  Goel S, 47th Annual Meeting of the American Society of Clinical Oncology, 6/1/2011
• “PIK3CA/PTEN mutation status predicts response of the colon cancer cells to the EGFR inhibitor cetuximab”
  Goel S, Jhawer M, Wilson AJ, et al, 2007 ECOG Young Investigators Symposium in Fort Lauderdale, FL, 1/1/2007
• Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamcis of Ixabepilone.
  Goel S, Goldberg G, Iacono L, et al, ASCO Annual Meeting Proceedings Part I, 6/20/2006
• First-in-human Phase 1 Trial of a Novel Epothilone, KOS-1584.
  Villalona-Calero M, Goel S, et al, Annual Meeting Proceedings Part I, 6/20/2006
• Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamcis of Ixabepilone.
  Goel S, Goldberg G, Iacono L, et al, Journal of Clinical Oncology, 1/1/2006
• First-in-human Phase 1 Trial of a Novel Epothilone, KOS-1584.
  Villalona-Calero M, Goel S, et al, Journal of Clinical Oncology, 1/1/2006
• “Phase I study monitoring extracellular PKA (ECPKA) in a continuous intravenous infusion (CIV) with GEM® 231, a second generation antisense oligonucleotide targeted ag...
  Goel S, Cho-Chung YS, Nesterova M, et al, Glaxo Smith-Kline National Oncology Fellows Forum. Feb 28-Mar 3, 2002, 2/28/2002
• “First Human Experience with GEM® 231, a second generation antisense oligonucleotide targeted against PKA R1 Alpha. Preliminary proof of concept using a novel assay fo...
  Goel S, Cho-Chung YS, Nesterova M, et al, Montefiore Young Investigators Symposium, 2/8/2002
• “Phase I Clinical Trial of Irinotecan with Oral Capecitabine in Patients with Gastrointestinal and other Solid Malignancies”
  Goel S, Rajdev L, Jhawer M, et a, ECOG Young Investigators Symposium held at Miami Beach, FL, Nov 9-12, 2001, 11/9/2001
• Join now to see all

Lectures

• Assessing Response to Therapy: Radiographic Response Criteria Review 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/5/2018
• Colorectal Cancer: Updates and Future Directions 
  Department of Pathology, Assam Medical College, Dibrugah, Assam, India - 10/1/2010
• Updates in Colorectal Cancer 
  Grand Rounds, Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine - 12/1/2006
• Chemotherapy for cancer of the urinary bladder 
  Grand Rounds, Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine - 12/1/2004
• Join now to see all